In the ever-evolving landscape of genomics and biotechnology, Next Generation Sequencing (NGS) has emerged as a transformative force. The NGS market has witnessed rapid growth in recent years, unlocking new possibilities in fields like healthcare, agriculture, and personalized medicine. This blog will explore the current state of the Next Generation Sequencing Market, shedding light on trends, applications, and the impact it has had on various industries.
Before we delve into the market dynamics, let's understand the basics of NGS. Next Generation Sequencing, also known as high-throughput sequencing, is a revolutionary technology that enables the rapid and cost-effective sequencing of DNA and RNA. It has replaced traditional Sanger sequencing and has brought genomics to the forefront of research and diagnostics.
The NGS market has seen impressive growth over the past decade. According to BCC Research, The global Next-Generation Sequencing (NGS) market for drug development is projected to achieve a value of $2.9 billion by 2028, experiencing a substantial compound annual growth rate (CAGR) of 17.7% from the baseline of $1.3 billion in 2023 during the forecast period spanning from 2023 to 2028.